MONTVALE, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that it will report its second quarter financial results on Thursday, August 9, 2007, before the U.S. financial markets open. Management will provide a Company update and discuss the second quarter results during a conference call on Thursday, August 9, 2007, at 9:00 a.m. EDT.
Investors and other interested parties may access the call as follows: Date: Thursday, August 9, 2007 Time: 9:00 a.m. EDT Telephone (U.S.): 866-713-8565 Telephone (international): 617-597-5324 Participant Passcode: 77253492 Webcast: http://www.memorypharma.com under the “Investors” section
An audio replay of the conference call will be available from 11:00 a.m. EDT on Thursday, August 9, 2007, until Thursday, August 16, 2007. To access the replay, please dial 888-286-8010 (U.S.) or 617-801-6888 (international) and enter pass code number 58601384. An audio replay of the conference call will also be available under the “Investors” section of the Company’s website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.
CONTACT: Jzaneen Lalani, General Counsel, +1-201-802-7249, for MemoryPharmaceuticals Corp.; or Laura Perry of Stern Investor Relations, Inc.,+1-212-362-1200
Web site: http://www.memorypharma.com/
